Sometimes it takes the Food and Drug Administration a very long time to spring into action. We have been badgering the agency ...

Earlier this month, the U.S. Food and Drug Administration (FDA) issued a warning regarding two popular allergy medications.

The itching, known medically as pruritus, was so bad that affected people described "significant and persistent impact on quality of life and ability to function." ...

Abruptly stopping these antihistamines after long-term use without tapering can lead to severe itching, the FDA said.

Just in time for allergy season, a recent FDA warning describes a new side effect for those who take Zyrtec or Xyzal ...

People who regularly use the allergy medications Zyrtec or Xyzal may experience severe itching when they stop, the U.S. Food ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical intervention,” the FDA said on Friday, May 16. The agency said ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

In “rare but severe” cases, and for unknown reasons, some who quit using the drugs became very itchy and had to seek medical help. “Reported cases were rare but sometimes serious ...